Evaluating patients with spontaneous intracranial hypotension remains a significant diagnostic challenge. When spinal magnetic resonance imaging shows no epidural fluid, clinicians frequently suspect a cerebrospinal fluid-venous fistula. However, initial dynamic or computed tomography myelography often fails to identify the culprit site. Consequently, clinicians face an uncertain dilemma regarding the utility of repeating the procedure. A landmark study now clarifies the clinical yield of repeat myelography in SIH, offering actionable guidance for refractory presentations.

The Challenge of Occult CSF-Venous Fistulas

Spontaneous intracranial hypotension typically causes incapacitating orthostatic headaches and vestibular distress. In the absence of extradural spinal fluid collections, a direct cerebrospinal fluid-venous fistula represents the underlying culprit in many cases. These microscopic channels allow rapid, unregulated drainage of spinal fluid into paraspinal veins. Because the leakage drains directly into venous circulation, conventional spine imaging often misses the defect entirely. Therefore, neurointerventional radiologists rely on specialized lateral decubitus CT myelography or digital subtraction myelography to visualize the vascular connection. Despite meticulous initial protocols, these fleeting lesions frequently evade identification. Patients may endure disabling symptoms for months while their initial investigations show completely nonlocalizing findings. Clinicians previously had limited objective evidence to determine whether repeating myelography provided meaningful clinical value. Furthermore, repeating invasive lumbar punctures carries procedural discomfort and minor risks. Neurologists therefore required clear predictive markers and defined diagnostic probabilities before requesting repeat examinations. This novel investigation directly answers this clinical dilemma by establishing robust baseline performance metrics.

Clinical Yield of Repeat Myelography in SIH

The retrospective study reviewed 71 consecutive patients who previously had a negative or nonlocalizing myelogram. In addition, the investigators examined a secondary cohort of 13 patients whose initial suspicious targets remained unresolved after targeted therapy. Overall, repeat myelography in the primary cohort definitively localized a CSF-venous fistula in 4.2 percent of individuals. Moreover, four additional patients demonstrated suspicious findings that resolved completely after targeted treatment. By incorporating treatment responsiveness, the study established a clinically supported diagnostic yield of 9.9 percent in the primary group. When combining both cohorts, the aggregate diagnostic yield reached 11.9 percent across 84 examinations. These data confirm that repeat imaging uncovers a definitive or clinically treatable lesion in approximately one in ten patients. Consequently, a previous negative myelogram should not deter clinicians from pursuing repeat evaluation in high-suspicion cases. Patients with persistent orthostatic disability benefit substantially from targeted transvenous embolization or surgical clipping once imaging localizes the fistula. Thus, repeat myelography offers a viable secondary diagnostic pathway for carefully selected candidates.

Impact of Bern Score and Headache Phenotypes

Radiologists frequently utilize the Bern score on brain magnetic resonance imaging to assess intracranial hypotension severity. In this investigation, researchers tracked whether higher Bern scores predicted greater success during repeat myelography. Clinically supported yields rose numerically from 7.3 percent in low Bern score tiers to 16.7 percent in patients with scores of five or greater. Although this numerical trend did not achieve statistical significance, it suggests severe cranial imaging signs correlate with underlying fistulas. Importantly, clinical headache features revealed a dramatic diagnostic correlation. Patients presenting with pressure-provoked or exertion-induced headache phenotypes demonstrated a 26.3 percent yield upon repeat myelography. In contrast, patients lacking this distinctive exertion-provoked phenotype had a yield of only 4.3 percent. Consequently, post hoc analysis showed a statistically significant relative risk of 6.18 for finding a fistula in exertion-triggered cases. Thus, clinical history provides crucial clues for patient stratification. Clinicians can actively prioritize repeat myelography for patients whose headaches intensify notably with Valsalva maneuvers or physical exertion.

Saline Augmentation and Technological Enhancements

Procedural technique strongly influences the detection of low-flow or intermittent fistulas during repeat spinal imaging. Notably, the study revealed that clinicians administered intrathecal saline augmentation in all seven clinically supported cases. In comparison, proceduralists utilized saline augmentation in only 52.5 percent of negative repeat examinations. This difference reached statistical significance, highlighting the potential role of volume boluses during myelography. By elevating the intrathecal opening pressure, saline infusions likely facilitate contrast transit through collapsed or intermittent fistulous tracts. Furthermore, scanner technology demonstrated a pivotal role in detecting subtle vascular channels. Within the secondary unresolved cohort, all three definitive fistula localizations occurred exclusively using photon-counting detector CT. Photon-counting CT provides ultra-high spatial resolution and superior soft-tissue contrast compared to conventional energy-integrating detectors. Therefore, it enables radiologists to distinguish diminutive draining veins adjacent to complex spinal neural elements. Combining saline augmentation with advanced photon-counting CT scanner platforms may substantially increase diagnostic sensitivity in future clinical protocols.

Practical Implications for Neurologists and Radiologists

These findings deliver practical, actionable insights for multidisciplinary neurovascular teams managing spontaneous intracranial hypotension. First, clinicians should not view an initial negative CT myelogram as an absolute diagnostic dead end. Instead, teams should weigh the overall pretest probability, brain imaging findings, and clinical presentation. When a patient exhibits incapacitating headaches exacerbated by physical exertion or Valsalva actions, repeat imaging carries substantial diagnostic value. Second, procedural teams should consider adopting saline augmentation protocols to transiently heighten intrathecal pressure before injecting contrast. This maneuver may unmask occult fistulas that remain dormant during baseline physiological states. Third, referral to advanced centers equipped with photon-counting detector CT myelography offers distinct diagnostic advantages. Such modern imaging modalities clearly detect diminutive fistulous connections that conventional scanners overlook. Finally, close collaboration between neurologists, radiologists, and spine surgeons ensures prompt targeted management once a fistula is successfully identified. Through thoughtful patient selection and optimized procedural methods, clinicians can resolve persistent CSF leaks and restore functional quality of life.

Frequently Asked Questions

What is the diagnostic yield of repeat myelography in SIH?

Repeat myelography provides a clinically supported diagnostic yield of roughly ten percent in patients with suspected spontaneous intracranial hypotension who had an earlier negative study. Definite CSF-venous fistulas emerge in approximately four percent of initial non-localizing cases. Additionally, another six percent of patients exhibit suspicious imaging targets that improve following targeted therapy. Consequently, repeat imaging remains a viable diagnostic option for individuals with persistent, disabling symptoms.

How does saline augmentation improve repeat myelography outcomes?

Saline augmentation involves infusing sterile saline into the spinal subarachnoid space before contrast injection. This procedural maneuver transiently elevates intrathecal opening pressure, preventing intermittent or low-flow CSF-venous fistulas from collapsing. In the study, all patients with clinically supported fistulas received saline augmentation during repeat myelography. Therefore, increasing intrathecal pressure helps opacify subtle paraspinal veins, significantly enhancing diagnostic sensitivity for subtle vascular channels that evade detection on standard baseline studies.

Which clinical features suggest a higher success rate for repeat myelography?

Patients with headaches provoked or aggravated by physical exertion, coughing, or Valsalva maneuvers demonstrate the highest diagnostic yield during repeat myelography. In clinical analysis, these patients achieved a 26.3 percent localization rate, representing a six-fold relative increase over non-exertional presentations. Furthermore, patients showing marked intracranial hypotension signs on brain MRI, reflected by elevated Bern scores of five or higher, exhibit greater numerical yields during secondary spinal investigations.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Clinical decisions should always be made by qualified healthcare professionals based on individual patient assessment, applicable institutional protocols, and current evidence-based medicine. Refer to the latest local and national guidelines for clinical practice.

References

1. Callen AL et al. Diagnostic Yield of Repeat Myelography After an Initial Negative Study in Patients With Suspected Spontaneous Intracranial Hypotension. AJNR Am J Neuroradiol. 2026 Sep 23. doi: undefined. PMID: 42778499.
2. Amrhein TJ et al. Myelography Using Energy-Integrating Detector CT Versus Photon-Counting Detector CT for Detection of CSF-Venous Fistulas in Patients With Spontaneous Intracranial Hypotension. AJR Am J Roentgenol. 2024;223(4):e2330607.
3. Madhavan AA et al. Benefits of Photon-Counting CT Myelography for Localization of Dural Tears in Spontaneous Intracranial Hypotension. AJNR Am J Neuroradiol. 2024;45(7):981-985.